Literature DB >> 16318477

The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis, and depression.

S K Johnson1, G Lange, J DeLuca, L R Korn, B Natelson.   

Abstract

The effects of fatigue on neuropsychological performance were examined in patients with fatiguing illnesses. Repeated testing with the Paced Auditory Serial Addition Test (PASAT; Gronwall, 1977) was employed over the course of a demanding neuropsychological testing session. It was hypothesized that if fatigue affects performance, one would expect to observe "blunting" of the PASAT practice effect. Fifteen of the study participants live with chronic fatigue syndrome (CFS), 15 with multiple sclerosis (MS), 14 with depression (DEP), and 15 are healthy, sedentary controls. Overall PASAT performance was significantly reduced for CFS and DEP participants compared to controls, whereas mean performance did not differ across the three fatiguing illness groups. Degree of improvement across trials (i.e., practice effect) for the groups did not differ from controls'. Neither subjective fatigue or DEP were significantly related to PASAT performance. These findings suggest that fatigue does not universally impair performance during neuropsychological assessment even in groups in which fatigue is a prominent symptom.

Entities:  

Year:  1997        PMID: 16318477     DOI: 10.1207/s15324826an0403_1

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  18 in total

1.  Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.

Authors:  Lei Wang; Alexandra C Apple; Matthew P Schroeder; Anthony J Ryals; Joel L Voss; Darren Gitelman; Jerry J Sweet; Zeeshan A Butt; David Cella; Lynne I Wagner
Journal:  Cancer       Date:  2015-10-20       Impact factor: 6.860

Review 2.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

Review 3.  Fatigue and Human Performance: An Updated Framework.

Authors:  Florian Husmann; Matthias Weippert; Martin Behrens; Martin Gube; Helmi Chaabene; Olaf Prieske; Alexandre Zenon; Kim-Charline Broscheid; Lutz Schega
Journal:  Sports Med       Date:  2022-10-18       Impact factor: 11.928

4.  Development and Validation of the State-Trait Inventory of Cognitive Fatigue in Community-Dwelling Older Adults.

Authors:  Melissa Shuman-Paretsky; Vance Zemon; Frederick W Foley; Roee Holtzer
Journal:  Arch Phys Med Rehabil       Date:  2016-08-26       Impact factor: 3.966

5.  Functional magnetic resonance imaging movers and shakers: does subject-movement cause sampling bias?

Authors:  Glenn R Wylie; Helen Genova; John DeLuca; Nancy Chiaravalloti; James F Sumowski
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

Review 6.  Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Authors:  Bridget Bagert; Patricia Camplair; Dennis Bourdette
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).

Authors:  Brigitte Greim; Reiner Benecke; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

8.  A Longitudinal Evaluation of Cognitive Fatigue on a Task of Sustained Attention in Early Relapsing-Remitting Multiple Sclerosis.

Authors:  Jason A Berard; Andra M Smith; Lisa A S Walker
Journal:  Int J MS Care       Date:  2018 Mar-Apr

9.  Subjective cognitive fatigue in multiple sclerosis depends on task length.

Authors:  Joshua Sandry; Helen M Genova; Ekaterina Dobryakova; John DeLuca; Glenn Wylie
Journal:  Front Neurol       Date:  2014-10-27       Impact factor: 4.003

10.  Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imaging.

Authors:  Helen M Genova; Venkateswaran Rajagopalan; John Deluca; Abhijit Das; Allison Binder; Aparna Arjunan; Nancy Chiaravalloti; Glenn Wylie
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.